Cilostazol: treatment of intermittent claudication (Q31989672)

5 July 2017

1 reference

title

Cilostazol: treatment of intermittent claudication (English)

1 reference

intermittent claudication

5 July 2017

main subject

1 reference

1 reference

M P Reilly

1

1 reference

5 July 2017

E R Mohler

series ordinal

2

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Annals of Pharmacotherapy

5 July 2017

published in

1 reference

5 July 2017

volume

35

1 reference

5 July 2017

issue

1

1 reference

5 July 2017

page(s)

48-56

1 reference

The Epidemiology of Peripheral Arterial Disease: Importance of Identifying the Population at Risk

5 July 2017

cites work

1 reference

Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis

21 January 2018

1 reference

A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial

21 January 2018

1 reference

Comparison of cilostazol versus ticlopidine therapy after stent implantation

21 January 2018

1 reference

Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors

21 January 2018

1 reference

Functional relationship between cyclic AMP-dependent protein phosphorylation and platelet inhibition

21 January 2018

1 reference

Effects of selective phosphodiesterase inhibitors on isolated coronary, lung and renal arteries from man and rat

21 January 2018

1 reference

Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells

21 January 2018

1 reference

The Effect of Cilostazol, a Cyclic Nucleotide Phosphodiesterase III Inhibitor, on Heparin-Binding EGF-like Growth Factor Expression in Macrophages and Vascular Smooth Muscle Cells

21 January 2018

1 reference

Changes of cyclic-AMP and cycic-AMP phosphodiesterase in the progression and regression of experimental atherosclerosis

21 January 2018

1 reference

Regulation of VLDL secretion in primary culture of rat hepatocytes: involvement of cAMP and cAMP-dependent protein kinases

21 January 2018

1 reference

Pharmacokinetics of Multiple‐Dose Oral Cilostazol in Middle‐Age and Elderly Men and Women

21 January 2018

1 reference

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

21 January 2018

1 reference

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

21 January 2018

1 reference

Thrombotic thrombocytopenic purpura associated with clopidogrel

21 January 2018

1 reference

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

21 January 2018

1 reference

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

21 January 2018

1 reference

A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators

21 January 2018

1 reference

Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.19408

1 reference

5 July 2017

1 reference